Carbon dot-based biosensors for the detection of communicable and non -communicable diseases.

Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference.

Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans.

Monitor biodiversity for action.

Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.

Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome.

Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemia.

Predicting liver-related serious adverse events in patients with primary biliary cholangitis-related cirrhosis treated with obeticholic acid.

Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial.

The optimal immunosuppression management to prevent early rejection after liver transplantation: A systematic review of the literature and expert panel recommendations.

Autoimmune hepatitis: Challenges and novelties.

Budesonide in the first line treatment of patients with autoimmune hepatitis.

Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study.

Noninvasive Prediction of Outcomes in Autoimmune Hepatitis-Related Cirrhosis.

Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis.